Drug Design, Development and Therapy (Dec 2017)
Guideline development for the management of gout: role of combination therapy with a focus on lesinurad [Corrigendum]
Abstract
Jones G, Panova E, Day R. Drug Des Devel Ther. 2017;11:3077–3081.On page 3078, Table 1, Abbreviation list, expansion for FBX was incorrectly listed as feboxustat, the correct spelling is febuxostat.Read the original article